If you keep up with hair loss news, you’ve almost certainly seen the headlines: a new breakthrough drug is regrowing 539% more hair. This news has exploded across social media and news outlets, with many hailing it as the long-awaited cure for baldness. The company behind the drug, known as Clascoterone or Breezula, even saw its stock price surge by 40%. On the surface, it sounds like the miracle we’ve all been waiting for. After all, if the current gold standard, Finasteride, increases hair counts by about 9%, a 539% increase must be world-changing, right? You might be tempted to throw out your current treatments and wait for this game-changer to hit the market.
But not so fast. As with many things that sound too good to be true, there’s a major catch. That incredible 539% figure is deeply misleading, and the company’s own data, both new and old, tells a very different story. In this article, we’re going to pull back the curtain on Clascoterone. We’ll dissect that headline-grabbing number, look at the clinical data the drug makers might not want you to see, and give you a realistic picture of what this new treatment can—and can’t—do. My goal is to help you navigate the often-confusing world of hair loss treatments so you can make the best decisions for your hair and your health. (Based on the insights of Rob English)
Key Takeaways
- The widely reported “539% increase in hair” from Clascoterone is not an absolute increase. It’s a misleading statistic comparing its tiny effect to the even tinier effect of a placebo.
- Past clinical trials showed that Clascoterone was less effective than Minoxidil, a common over-the-counter hair loss treatment.
- The before-and-after photos released by the company are underwhelming and likely represent the absolute best-case results from a 1,500-person study.
- Patient self-assessments of hair growth were weak, with one of the two major studies failing to show a statistically significant improvement.
- You should not delay or stop using proven hair loss treatments like Finasteride or Minoxidil while waiting for Clascoterone to become available.
1. What Is Clascoterone? The Basics Explained
First, let’s understand what this drug actually is. Clascoterone is a topical medication, meaning you apply it directly to your scalp. It works as an androgen receptor antagonist. Think of your hair follicle cells as having little landing pads (receptors) for male hormones (androgens) like DHT (dihydrotestosterone). In androgenic alopecia (male and female pattern hair loss), DHT binds to these receptors and triggers the process of hair follicle miniaturization, which leads to thinning and balding.
Clascoterone works by blocking these landing pads. If DHT can’t attach to the cell, it can’t send the signal to shrink the hair follicle. The big appeal is that it’s designed to work locally on the scalp with minimal absorption into the rest of your body, which could mean fewer systemic side effects. In fact, a 1% version of this drug is already FDA-approved to treat acne in teenagers, suggesting a strong safe